Optimized reference region and the effect on test-retest reliability and detection of Parkinson's disease with UCB-J.
Nikkita KhattariD, David MatuskeyiD, Jean‐Dominique GallezotiD, Mika NaganawaiD, Sophie E. HolmesiD, Faranak Ebrahimian SadabadiD, Mahsa MayeliiD, Irina EsterlisiD, Christopher H. van DyckiD, Adam P. MeccaiD, Deepak Cyril D’SouzaiD, Nabeel NabulsiiD, Sjoerd J. FinnemaiD, Yiyun Henry HuangiD, Richard E. CarsoniD, Takuya ToyonagaiD
Abstract
[11C]UCB-J is a radioligand targeting synaptic vesicle glycoprotein 2A, used to image synaptic density. For quantification, a small-volume centrum semiovale area was previously optimized as a [11C]UCB-J reference region (CS2mL); however, its high variability resulted in reduced reliability. Herin, we evaluated an alternative reference region method to assess longitudinal test-retest reliability and detection of Parkinsons disease (PD). For estimating distribution volume ratio (DVR), CS2mL and eleven white matter (WM) reference regions (range: 0.5-200 mL) were generated using the Freesurfer WM map. Same-day and longitudinal test-retest variability (TRV) were assessed (24 healthy subjects (HS); n=10 same-day and n=20 longitudinal HRRT scans, range: 7-1028 days). Each reference region was used to evaluate the substantia nigra (SN) and caudate DVRs in HS (n=25) and PD (n=20). The 10mL WM reference region yielded [11C]UCB-J DVR measurements with reduced variability in TRV (same-day: 10mL: 1.2{+/-}5.7%, same-day: CS2mL: -0.9{+/-}9.2% longitudinal: 10mL: 1.5{+/-}7.0%, CS2mL: 1.6{+/-}11.9%,) while maintaining <10% volume of distribution difference, compared to CS2mL. Further, a significant difference between PD and HS groups in SN and caudate DVRs was found using 10mL, with greater effect size (Cohens d 0.61 for SN and 0.66 for caudate) compared to CS2mL (0.38 for SN and 0.43 for caudate).
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Discovery and characterization of UCB-1A: the first PET radioligand for imaging synaptic vesicle glycoprotein 2C
Sangram Nag, Vasco C. Sousa, … Andrea Varrone·bioRxiv·Mar 10, 2026
- Synaptic density and neuronal metabolic function measured by PET in the unilateral 6-OHDA rat model of Parkinson's disease
Nakul Ravi Raval, Frederik Gudmundsen, … Mikael Palner·Frontiers in Synaptic NeurosciencePeer-reviewed·Nov 18, 2021
- Imaging Synaptic Vesicle Protein SV2C with 18F-UCB-F: An In Vitro Autoradiography and In Vivo NHP PET Study
Sangram Nag, V. C. Sousa, … Andrea Varrone·ACS Chemical NeurosciencePeer-reviewed·Jun 26, 2026
- The practical impact of numerical variability on structural MRI measures of Parkinson's disease
Yohan Chatelain, Andrzej Sokołowski, … Tristan Glatard·Scientific ReportsPeer-reviewed·Aug 13, 2026
- Preclinical validation and kinetic modelling of the SV2A PET ligand UCB-J in mice
Liesbeth Everix, Filipe Elvas, … Daniele Bertoglio·Journal of Cerebral Blood Flow & MetabolismPeer-reviewed·Dec 4, 2024
- The impact of FreeSurfer versions on structural neuroimaging analyses of Parkinson's disease
Andrzej Sokołowski, Nikhil Bhagwat, … Tristan Glatard·bioRxiv·Nov 11, 2024